802 related articles for article (PubMed ID: 23806868)
1. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
2. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
Langen RC; Gosker HR; Remels AH; Schols AM
Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
[TBL] [Abstract][Full Text] [Related]
3. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of glucocorticoid-induced myopathy.
Schakman O; Gilson H; Thissen JP
J Endocrinol; 2008 Apr; 197(1):1-10. PubMed ID: 18372227
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of muscle atrophy induced by glucocorticoids.
Schakman O; Gilson H; Kalista S; Thissen JP
Horm Res; 2009 Nov; 72 Suppl 1():36-41. PubMed ID: 19940494
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
9. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
10. Effects of 3 days unloading on molecular regulators of muscle size in humans.
Gustafsson T; Osterlund T; Flanagan JN; von Waldén F; Trappe TA; Linnehan RM; Tesch PA
J Appl Physiol (1985); 2010 Sep; 109(3):721-7. PubMed ID: 20538844
[TBL] [Abstract][Full Text] [Related]
11. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
[TBL] [Abstract][Full Text] [Related]
12. Lack of contribution of 11betaHSD1 and glucocorticoid action to reduced muscle mass associated with reduced growth hormone action.
Itoh E; Iida K; Kim DS; Del Rincon JP; Coschigano KT; Kopchick JJ; Thorner MO
Growth Horm IGF Res; 2004 Dec; 14(6):462-6. PubMed ID: 15519255
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.
Jones A; Hwang DJ; Narayanan R; Miller DD; Dalton JT
Endocrinology; 2010 Aug; 151(8):3706-19. PubMed ID: 20534726
[TBL] [Abstract][Full Text] [Related]
14. Is there a common mechanism linking muscle wasting in various disease types?
Tisdale MJ
Curr Opin Support Palliat Care; 2007 Dec; 1(4):287-92. PubMed ID: 18685377
[TBL] [Abstract][Full Text] [Related]
15. β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells.
Kimura K; Cheng XW; Inoue A; Hu L; Koike T; Kuzuya M
Nutr Res; 2014 Apr; 34(4):368-74. PubMed ID: 24774073
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle.
Liu Z; Li G; Kimball SR; Jahn LA; Barrett EJ
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E275-81. PubMed ID: 15039148
[TBL] [Abstract][Full Text] [Related]
18. Regulation of muscle protein synthesis during sepsis and inflammation.
Lang CH; Frost RA; Vary TC
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E453-9. PubMed ID: 17505052
[TBL] [Abstract][Full Text] [Related]
19. Regulation of muscle protein synthesis and the effects of catabolic states.
Gordon BS; Kelleher AR; Kimball SR
Int J Biochem Cell Biol; 2013 Oct; 45(10):2147-57. PubMed ID: 23769967
[TBL] [Abstract][Full Text] [Related]
20. REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy.
Britto FA; Begue G; Rossano B; Docquier A; Vernus B; Sar C; Ferry A; Bonnieu A; Ollendorff V; Favier FB
Am J Physiol Endocrinol Metab; 2014 Dec; 307(11):E983-93. PubMed ID: 25315696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
